Frédéric Sedel, MD
Chief Executive Officer
Dr Frédéric Sedel, MD, PhD, is co-founder and Chief Executive Officer (CEO) of MedDay. He is a trained neurologist and neuroscientist after completing his PhD at Ecole Normale Supérieure (Paris), where he studied Inborn Errors of Metabolism (IEM) with Prof. Saudubray at the Necker Children’s Hospital (Paris). Between 2004 and 2013, Dr Sedel founded and coordinated the Neurometabolic Department of Pitié-Salpêtrière Hospital dedicated to treating adults with IEM. Dr Sedel has been part of the Reference Centre for Lysosomal Diseases, Vice President of the French Society for IEM, and President of the SSIEM European Adult Metabolic Group. He has published around 80 peer-reviewed articles, mostly dedicated to IEMs in adult neurology, and has spoken at more than 30 leading international conferences over the last 5 years. He co-founded MedDay in 2011 with Guillaume Brion and became CEO in November 2013.